CRACD suppresses neuroendocrinal plasticity of lung adenocarcinoma

Tumor cell plasticity contributes to intratumoral heterogeneity and therapy resistance. Through cell plasticity, lung adenocarcinoma (LUAD) cells transform into neuroendocrinal (NE) tumor cells. However, the mechanisms of NE cell plasticity remain unclear. CRACD, a capping protein inhibitor, is freq...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Bongjun, Zhang, Shengzhe, Huang, Yuanjian, Ko, Kyung-Pil, Zou, Gengyi, Zhang, Jie, Jun, Sohee, Kim, Kee-Beom, Jung, Youn-Sang, Park, Kwon-Sik, Park, Jae-Il
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153265/
https://www.ncbi.nlm.nih.gov/pubmed/37131761
http://dx.doi.org/10.1101/2023.04.19.537576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153265/
https://www.ncbi.nlm.nih.gov/pubmed/37131761
http://dx.doi.org/10.1101/2023.04.19.537576

Ejemplares similares